Thao P. Le

Array ( [id] => 14277917 [patent_doc_number] => 20190136243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-09 [patent_title] => METHOD FOR PREVENTING OR TREATING OBESITY BY USING A COMPOSITION INCLUDING HOGA1-INHIBITING SUBSTANCE AND METHOD OF SCREENING A PREVENTIVE OR THERAPEUTIC AGENT FOR OBESITY BY USING THE COMPOSITION [patent_app_type] => utility [patent_app_number] => 16/181835 [patent_app_country] => US [patent_app_date] => 2018-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8780 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16181835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15210453 [patent_doc_number] => 20190367913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-05 [patent_title] => RIBOZYME WITH tRNA SYNTHETASE ACTIVITY AND METHODS OF MANUFACTURING AND USING THE SAME [patent_app_type] => utility [patent_app_number] => 16/175452 [patent_app_country] => US [patent_app_date] => 2018-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18618 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16175452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16703122 [patent_doc_number] => 10953035 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-23 [patent_title] => Compositions and methods for treating and preventing end stage renal disease [patent_app_type] => utility [patent_app_number] => 16/171952 [patent_app_country] => US [patent_app_date] => 2018-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 20253 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16171952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16650213 [patent_doc_number] => 10927378 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-02-23 [patent_title] => Compound and method for treating myotonic dystrophy [patent_app_type] => utility [patent_app_number] => 16/163948 [patent_app_country] => US [patent_app_date] => 2018-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7205 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16163948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17306260 [patent_doc_number] => 11207342 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-28 [patent_title] => High density lipoprotein binding protein (Hdlbp/Vigilin) iRNA compositions and methods of use thereof [patent_app_type] => utility [patent_app_number] => 16/162705 [patent_app_country] => US [patent_app_date] => 2018-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 81 [patent_no_of_words] => 42442 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16162705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17756370 [patent_doc_number] => 11396654 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-26 [patent_title] => Neutral nanotransporters [patent_app_type] => utility [patent_app_number] => 16/159590 [patent_app_country] => US [patent_app_date] => 2018-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 48 [patent_no_of_words] => 30826 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16159590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13793923 [patent_doc_number] => 20190010500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-10 [patent_title] => PREVENTIVE OR THERAPEUTIC AGENT FOR FIBROSIS [patent_app_type] => utility [patent_app_number] => 16/139461 [patent_app_country] => US [patent_app_date] => 2018-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8638 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16139461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15306417 [patent_doc_number] => 10517889 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-31 [patent_title] => Modulators of SMAD7 expression [patent_app_type] => utility [patent_app_number] => 16/124583 [patent_app_country] => US [patent_app_date] => 2018-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58633 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16124583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16650209 [patent_doc_number] => 10927374 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-02-23 [patent_title] => Compositions and methods for controlling arthropod parasite and pest infestations [patent_app_type] => utility [patent_app_number] => 16/125048 [patent_app_country] => US [patent_app_date] => 2018-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 27943 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16125048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15606573 [patent_doc_number] => 10584336 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-10 [patent_title] => Oligomeric compounds and compositions for use in modulation of small non-coding RNAs [patent_app_type] => utility [patent_app_number] => 16/123554 [patent_app_country] => US [patent_app_date] => 2018-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 119485 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16123554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16998424 [patent_doc_number] => 11077206 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-03 [patent_title] => Composition for gene therapy or transfection, and preparation method and use thereof [patent_app_type] => utility [patent_app_number] => 16/465573 [patent_app_country] => US [patent_app_date] => 2018-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 21 [patent_no_of_words] => 4307 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16465573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17421496 [patent_doc_number] => 11254941 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-22 [patent_title] => RNA nanostructures and methods of making and using RNA nanostructures [patent_app_type] => utility [patent_app_number] => 16/642792 [patent_app_country] => US [patent_app_date] => 2018-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 118 [patent_no_of_words] => 53028 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16642792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13982655 [patent_doc_number] => 20190060485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-28 [patent_title] => MATERIALS AND METHODS FOR EFFECTIVE IN VIVO DELIVERY OF DNA NANOSTRUCTURES TO ATHEROSCLEROTIC PLAQUES [patent_app_type] => utility [patent_app_number] => 16/113454 [patent_app_country] => US [patent_app_date] => 2018-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22543 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16113454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14277911 [patent_doc_number] => 20190136240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-09 [patent_title] => NUCLEIC ACID APTAMERS [patent_app_type] => utility [patent_app_number] => 16/104970 [patent_app_country] => US [patent_app_date] => 2018-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25390 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16104970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13958425 [patent_doc_number] => 20190055556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-21 [patent_title] => Targeting pleiotrophin signaling to limit high-grade glioma invasion [patent_app_type] => utility [patent_app_number] => 15/998437 [patent_app_country] => US [patent_app_date] => 2018-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30044 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15998437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16513230 [patent_doc_number] => 20200392488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-17 [patent_title] => METHOD FOR SCREENING SPLICING VARIANTS OR EVENTS [patent_app_type] => utility [patent_app_number] => 16/638100 [patent_app_country] => US [patent_app_date] => 2018-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12486 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16638100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15279901 [patent_doc_number] => 10512600 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-24 [patent_title] => RNA complexes that inhibit melanin production [patent_app_type] => utility [patent_app_number] => 16/102155 [patent_app_country] => US [patent_app_date] => 2018-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 14 [patent_no_of_words] => 13125 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16102155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17822887 [patent_doc_number] => 11427826 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-30 [patent_title] => RNA aptamers against transferrin receptor (TfR) [patent_app_type] => utility [patent_app_number] => 16/637679 [patent_app_country] => US [patent_app_date] => 2018-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 16 [patent_no_of_words] => 25970 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16637679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16028679 [patent_doc_number] => 10676748 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-09 [patent_title] => Aptamers for consumer product compositions [patent_app_type] => utility [patent_app_number] => 16/059396 [patent_app_country] => US [patent_app_date] => 2018-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 18635 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16059396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16223066 [patent_doc_number] => 20200248182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-06 [patent_title] => APTAMERS, BIOSENSORS AND DETECTION METHODS FOR COMMON AZOLE-CLASS ANTIFUNGAL DRUGS [patent_app_type] => utility [patent_app_number] => 16/637459 [patent_app_country] => US [patent_app_date] => 2018-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8271 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16637459 [rel_patent_id] =>[rel_patent_doc_number] =>)